Advertisement

Labeled Platelets in Idiopathic Thrombocytopenic Purpura

  • A. Moisan
  • T. Lamy
  • A. Devillers
  • J. Le Cloirec
  • P. Y. Le Prise
  • J. Y. Herry
Part of the NATO ASI Series book series (NSSA, volume 262)

Abstract

Idiopathic thrombocytopenia purpura (ITP) in adults is a relatively common hematologic problem. Splenectomy is seen as therapeutic means to increase the incidence of definitive remission in patients with chronic ITP. The predictive factors at short and long term success of splenectomy are still ill-defined and questioned13.

Keywords

Idiopathic Thrombocytopenic Purpura Immune Thrombocytopenic Purpura Autologous Platelet Platelet Destruction Chronic Idiopathic Thrombocytopenic Purpura 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood; 74: 2309–2317 (1989).PubMedGoogle Scholar
  2. 2.
    Danpure HJ, Osman S, Peters AM. Labelling autologous platelets with 111In tropolonate for platelet kinetic studies: limitations imposed by thrombocytopenia. Eur. J. Haematol.; 45: 223–230 (1990)PubMedCrossRefGoogle Scholar
  3. 3.
    Difino SM, Lachant NA, Kirshner JJ and al. Adult idiopathic thrombocytopenic purpura: clinical findings and response to therapy. Am. J. Med; 69: 430–442 (1980).PubMedCrossRefGoogle Scholar
  4. 4.
    Fabris F, Zanatta N, Casonato A and al. Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation. Acta Haemat.; 81: 28–33 (1989).PubMedCrossRefGoogle Scholar
  5. 5.
    Fenaux P, Caulier MT, Hirschauer MC and al. Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): a report on 181 cases. Eur. J. Haematol. 42: 259–264 (1989).PubMedCrossRefGoogle Scholar
  6. 6.
    Gernsheimer T, Stratton J, Ballem PJ, Slichter SJ. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N. Engl. J. Med.; 320: 974–980 (1989).PubMedCrossRefGoogle Scholar
  7. 7.
    Gugliotta L, Isacchi G, Guarini A and al. Chronic idiopathic thrombocytopenic purpura (ITP): site of platelet sequestration and results of splenectomy. A study of 197 patients. Scandinavian Journal of Haematol.; 26: 407–412 (1981).CrossRefGoogle Scholar
  8. 8.
    Heyns A du P, Badenhorst PN, Lotter MG and al. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood; 67: 86–92 (1986).PubMedGoogle Scholar
  9. 9.
    International Commitee for standardization in Hematology panel on diagnostic applications of Radionuclides (ICSH). J. Nucl Med.; 29: 564–566 (1988).Google Scholar
  10. 10.
    Julia A, Araguas C, Rossello J and al. Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura. Br. J. Haematol.; 76: 250–255 (1990).PubMedCrossRefGoogle Scholar
  11. 11.
    Karpatkin S. Autoimmune thrombocytopenic purpura. Blood; 56: 329–343 (1980).PubMedGoogle Scholar
  12. 12.
    Lamy T, Moisan A, Dauriac C, Ghandour C, Morice P, Le Prise PY. Splenectomy in idiopathic thrombocytopenic purpura: ITS correlation with the sequestration of autologous indium-111-labeled platelets. J. Nucl. Med., 34: 182–186 (1993).PubMedGoogle Scholar
  13. 13.
    McVerry BA. Management of idiopathic thrombocytopenic purpura in adults. Br. J. Haematol.; 59: 203–208 (1985).PubMedCrossRefGoogle Scholar
  14. 14.
    Mintz S, Petersen SR, Cheson B and al. Splenectomy for immune. Thrombocytopenic Purpura. Arch. Surg.; 116:645–650 (1981).PubMedCrossRefGoogle Scholar
  15. 15.
    Moisan A, Le Prise PY, Le Cloirec J and al. 111-Indium labelled platelets in thrombocytopenic purpura survival and biodistribution studied with scintillation camera. A review of 485 patients. In Kessler Ch, Hardeman M.R., Henningsen H. and Petrovici J.N. (Eds), Clinical application of radiolabelled platelets, Kluwer Academic Publishers 1990; 248–257.Google Scholar
  16. 16.
    Najean Y, Ardaillou N. The sequestration site of platelets in idiopathic thrombocytopenic purpura: its correlation with the results of splenectomy. Br. J. Haematol.; 21: 153–164 (1971).PubMedCrossRefGoogle Scholar
  17. 17.
    Najean Y, Dufour Y, Rain JD, Toubert ME. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy. Br. J. Haematol.; 79: 271–276 (1991).PubMedCrossRefGoogle Scholar
  18. 18.
    Najean Y, Lecompte T. Chronic pure thrombocytopenia in elderly patients. Cancer; 64: 2506–2510 (1989).PubMedCrossRefGoogle Scholar
  19. 19.
    Peters AM, Saverymuttu SH, Wonke B and al. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction. Br. J. Haematol; 57: 637–649 (1984).PubMedGoogle Scholar
  20. 20.
    Pizzuto J, Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: multicentric trial of the cooperative latin american group on hemostasis and thrombosis. Blood; 64: 1179–1183 (1984).PubMedGoogle Scholar
  21. 21.
    Reiffers J, Vuillemin L, Broustet A, Ducassou D. Kinetic study of Indium-111 labelled platelets in idiopathic thrombocytopenic purpura (in french). Nouv. Press Med.; 11: 2335–2338 (1982).Google Scholar
  22. 22.
    Richards JDM, Thompson DS. Assessment of thrombocytopenic patients for splenectomy. J. Clin. Pathol.; 32: 1248–1252 (1979).PubMedCrossRefGoogle Scholar
  23. 23.
    Ries CA. Platelets kinectics in auto-immune thrombocytopenia: relation between splenic platelet sequestration and response to splenectomy. Ann. Intern. Med.; 86: 194–195 (1977)PubMedGoogle Scholar
  24. 24.
    Siegel RS, Rae JL, Barth S and al. Platelet survival and turnover:Important factors in predicting response to splenectomy in immune thrombocytopenic purpura. Am. J. Hematol.; 30: 206–212 (1989).PubMedCrossRefGoogle Scholar
  25. 25.
    Stratton JR, Ballem PJ, Gernheimer T, Cerqueira M, Slichton SJ. Platelet destruction in autoimmune thrombocytopenic purpura: Kinetics and clearance of Indium 111-labeled autologous platelets. JNM,; 30: 629–737 (1989).PubMedGoogle Scholar
  26. 26.
    Thakur ML, Welch MJ, Joist JH, Coleman RI. Indium-111-labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thrombo Res.; 9: 345–357 (1976).CrossRefGoogle Scholar
  27. 27.
    Vanreenen O, Lotter MG, Heyns AP, Kock F, Herbst C. Kotle H, Pieters H, Minnaar PC, Badenhorst PN. Quantification of the destribution of 111In labelled platelets in organs. Eur. J. Nucl. Med.; 780–784 (1982).Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • A. Moisan
    • 1
  • T. Lamy
    • 1
  • A. Devillers
    • 1
  • J. Le Cloirec
    • 1
  • P. Y. Le Prise
    • 1
  • J. Y. Herry
    • 1
  1. 1.CAC — CHURennesFrance

Personalised recommendations